Marbofloxacin (Compound)

Synonyms:Marbofloxacin, 115550-35-1, Marbocyl, Zeniquin, Marbofloxacine, DTXSID4046600, 8X09WU898T, 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid, 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic acid, NCGC00166310-01, RO 09-1168, 7H-Pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic acid, Marbofloxacin [INN], DTXCID2026600, Marbofloxacine [INN-French], Marbofloxacinum [INN-Latin], Marbofloxacino [INN-Spanish], CAS-115550-35-1, Marbofloxacin [INN:BAN], UNII-8X09WU898T, CCRIS 8212, 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic Acid, 9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic acid, MFCD00864820, Marbofloxacin (USP/INN), MARBOFLOXACIN [MI], Oprea1_079403, MARBOFLOXACIN [MART.], SCHEMBL134860, CHEMBL478120, CHEBI:94723, EX-A015, MARBOFLOXACIN [GREEN BOOK], HY-B0126, RKL10084, Marbofloxacin for peak identification, Tox21_112406, s1464, AKOS015853291, Tox21_112406_1, BCP9000896, CCG-229989, CS-1892, DB11426, GS-3323, NCGC00166310-02, NCGC00166310-03, 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid, 7H-Pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, 9-Fluoro-3,7-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2H-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic Acid, AC-24289, BM164656, DB-041275, FT-0628168, M2240, D08156, H10130, AB01566820_01, Marbofloxacin, VETRANAL(TM), analytical standard, Q909359, SR-01000772975, Q-201338, SR-01000772975-2, Marbofloxacin, European Pharmacopoeia (EP) Reference Standard, Marbofloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard, 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2- diazatricyclo[7.3.1.0^5,13^]trideca-5,7,9(13),11-tetraene-11-carboxylic acid, 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.0^{5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid, 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.0^{5,13}]trideca-5,7,9(13),11-tetraene-11-carboxylic acid, 7-Fluoro-2-methyl-6-(4-methylpiperazin-4-ium-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate, 7H-1,3,4-Oxadiazino[6,5,4-ij]quinoline-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl -1-piperazinyl)-7-oxo-7H-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)- 7-oxo-7H-pyrido[1,2,3-ij][1,2,4]benzoxadiazine-6-carboxylic acid

Pubchem:PUBCHEM:60651

Id:8d400038-2ae7-57c2-b48c-d41ce5e73f73

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Marbofloxacin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Marbofloxacin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Marbofloxacin.

Results found

Linked to

	Label	Description
	BRD-K71926323-001-12-0 Substance (Entity type)	A Substance
	DCSTRUCT ID 05572 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05572; PubChem_CID:60651, FILE=drugcentral_drug_05572.json)
	marbofloxacin (e578beba-6303-44fb-827a-61c3fd4c6149) Collection (Entity type)	Metadatata for marbofloxacin
	Marbofloxacin negatively regulates QPCT Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Marbofloxacin negatively regulates NPY1R Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Marbofloxacin positively regulates RNASE6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	2,6-Di-tert-butyl-4-[1-(3,5-di-tert-butyl-4-hydroxy-phenylsulfanyl)-1-methyl-ethylsulfanyl]-phenol::2,6-di(tert-butyl)-4-{1-[3,5-di(tert-butyl)-4-hydroxyphenylsulfanyl]-1-methylethylsulfanyl}phenol::2,6-di(tert-butyl)-4-{1-[3,5-di(tert-butyl)-4-hydroxyphenylsulfanyl]-1-methylethylsulfanyl}phenol(probucol)::2,6-di-tert-butyl-4-(2-(3,5-di-tert-butyl-4-hydroxyphenylthio)propan-2-ylthio)phenol::CHEMBL608::DH-581::Lorelco::PROBUCOL::US9182402, 14 in similarity relationship with Marbofloxacin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	(S)-1-[(S)-2-Hydroxy-4-((R)-(R)-2-hydroxy-indan-1-ylcarbamoyl)-5-(S)-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide in similarity relationship with Marbofloxacin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Pargyline in similarity relationship with Marbofloxacin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Marbofloxacin positively regulates PSMD10 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K71926323-001-12-0

Substance (Entity type)

A Substance

DCSTRUCT ID 05572

Collection (Entity type)

DrugPage Collection: (DrugCentralID:05572; PubChem_CID:60651, FILE=drugcentral_drug_05572.json)

marbofloxacin (e578beba-6303-44fb-827a-61c3fd4c6149)

Collection (Entity type)

Metadatata for marbofloxacin

Marbofloxacin negatively regulates QPCT

Knowledge Graph Assertion (Entity type)